上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。
680C91
680C91 是一种口服有效的，选择性色氨酸 2,3-双加氧酶 (TDO) 抑制剂，Ki 为 51 nM。TDO 是色氨酸分解代谢的关键酶。680C91 可用于肿瘤免疫和阿尔茨海默症的研究。
680C91 Chemical Structure
CAS No. : 163239-22-3
| 规格 |
|
是否有货 |
|
| 100 mg |
|
询价 |
|
| 250 mg |
|
询价 |
|
| 500 mg |
|
询价 |
|
* Please select Quantity before adding items.
| 生物活性 |
680C91 is an orally active, selective tryptophan 2,3-dioxygenase (TDO) inhibitor with a Ki of 51 nM. TDO is the key enzyme of tryptophan catabolism. 680C91 can be used for the research of cancer immunotherapy and Alzheimer’s Disease[1][2][3][4].
|
体外研究
(In Vitro) |
680C91 is a potent (Ki=51 nM) and selective TDO inhibitor with no inhibitory activity against indoleamine 2,3-dioxygenase, monoamine oxidase A and B, 5-HT uptake and 5-HT1A,1D,2A and 2C receptors at a concentration of 10 μM[2].
680C91 inhibits the catabolism of tryptophan by rat liver cells and rat liver perfused in situ[2].
Tdo2 could regulate cell proliferation and stimulate the expression of decidual marker Dtprp in the uterine stromal cells and decidual cells. Tdo2 inhibitor 680C91 also inhibits the prolifer ation activity of uterine decidual cells at 24 h[3].
Treatment of leiomyoma smooth muscle cell (LSMC) and myometrial smooth muscle cell (MSMC) spheroids with 680C91 (25 and 50 μM) significantly represses the expression of collagen type I (COL1A1) and type III (COL3A1) in a dose-dependent manner[4].
上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay[3]
| Cell Line: |
Uterine stromal cells |
| Concentration: |
0.01, 0.05, 0.1, 0.5, 1, 5, and 10 μM |
| Incubation Time: |
24 hours |
| Result: |
The proliferation activity of stromal cells was significantly decreased at 5 and 10 μM. |
Western Blot Analysis[4]
| Cell Line: |
MSMC and LSMC |
| Concentration: |
25 and 50 μM |
| Incubation Time: |
48 hours |
| Result: |
Significantly reduced the expression of COL1A1 and COL3A1 in LSMC spheroids with no significant effect on expression of these proteins in MSMC spheroids. |
|
体内研究
(In Vivo) |
680C91 (a dose of 15 mg/kg for acute treatment ) elevates tryptophan in brain[5].
上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: |
Male C57Bl6/NCrl mice aged 13-18 weeks[5] |
| Dosage: |
15 mg/kg |
| Administration: |
Administered per os |
| Result: |
Caused a significant increase in brain tryptophan. |
|
| 分子量 |
|
| Formula |
|
| CAS 号 |
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis.
|
| 参考文献 |
-
[1]. M Salter, et al. The effects of an inhibitor of tryptophan 2,3-dioxygenase and a combined inhibitor of tryptophan 2,3-dioxygenase and 5-HT reuptake in the rat. Neuropharmacology. 1995 Feb;34(2):217-27.
[2]. M Salter, et al. The effects of a novel and selective inhibitor of tryptophan 2,3-dioxygenase on tryptophan and serotonin metabolism in the rat. Biochem Pharmacol. 1995 May 17;49(10):1435-42.
[3]. Dang-Dang Li, et al. Differential expression and regulation of Tdo2 during mouse decidualization. J Endocrinol. 2013 Dec 2;220(1):73-83.
[4]. Tsai-Der Chuang, et al. Tryptophan catabolism is dysregulated in leiomyomas. Fertil Steril. 2021 Oct;116(4):1160-1171.
[5]. Sophie Imbeault, et al. Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation. Acta Neuropsychiatr. 2020 Feb;32(1):43-53.
|
所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务
